United States - English - NLM (National Library of Medicine)

novel laboratories, inc. - phenelzine sulfate (unii: 2681d7p965) (phenelzine - unii:o408n561gf) - phenelzine 15 mg - phenelzine sulfate tablets, usp has been found to be effective in depressed patients clinically characterized as “atypical,” “nonendogenous,” or “neurotic.” these patients often have mixed anxiety and depression and phobic or hypochondriacal features. there is less conclusive evidence of its usefulness with severely depressed patients with endogenous features. phenelzine sulfate tablets should rarely be the first antidepressant drug used. rather, it is more suitable for use with patients who have failed to respond to the drugs more commonly used for these conditions. phenelzine sulfate tablets should not be used in patients who are hypersensitive to the drug or its ingredients, with pheochromocytoma, congestive heart failure, severe renal impairment or renal disease, a history of liver disease, or abnormal liver function tests. the potentiation of sympathomimetic substances and related compounds by mao inhibitors may result in hypertensive crises (see warnings). therefore, patients being treated with phenelzi

United States - English - NLM (National Library of Medicine)

lupin pharmaceuticals,inc. - phenelzine sulfate (unii: 2681d7p965) (phenelzine - unii:o408n561gf) - phenelzine 15 mg - phenelzine sulfate tablets, usp has been found to be effective in depressed patients clinically characterized as "atypical," "nonendogenous," or "neurotic." these patients often have mixed anxiety and depression and phobic or hypochondriacal features. there is less conclusive evidence of its usefulness with severely depressed patients with endogenous features. phenelzine sulfate tablets should rarely be the first antidepressant drug used. rather, it is more suitable for use with patients who have failed to respond to the drugs more commonly used for these conditions. phenelzine sulfate tablets should not be used in patients who are hypersensitive to the drug or its ingredients, with pheochromocytoma, congestive heart failure, severe renal impairment or renal disease, a history of liver disease, or abnormal liver function tests. the potentiation of sympathomimetic substances and related compounds by mao inhibitors may result in hypertensive crises (see warnings). therefore, patients being treated with phenelzi

United States - English - NLM (National Library of Medicine)

greenstone llc - phenelzine sulfate (unii: 2681d7p965) (phenelzine - unii:o408n561gf) - phenelzine 15 mg - phenelzine sulfate has been found to be effective in depressed patients clinically characterized as "atypical," "nonendogenous," or "neurotic." these patients often have mixed anxiety and depression and phobic or hypochondriacal features. there is less conclusive evidence of its usefulness with severely depressed patients with endogenous features. phenelzine sulfate should rarely be the first antidepressant drug used. rather, it is more suitable for use with patients who have failed to respond to the drugs more commonly used for these conditions. phenelzine sulfate should not be used in patients who are hypersensitive to the drug or its ingredients, with pheochromocytoma, congestive heart failure, severe renal impairment or renal disease, a history of liver disease, or abnormal liver function tests. the potentiation of sympathomimetic substances and related compounds by mao inhibitors may result in hypertensive crises (see warnings). therefore, patients being treated with phenelzine sulfate should not take sy

United States - English - NLM (National Library of Medicine)

golden state medical supply, inc. - phenelzine sulfate (unii: 2681d7p965) (phenelzine - unii:o408n561gf) - phenelzine 15 mg

United States - English - NLM (National Library of Medicine)

parke-davis div of pfizer inc - phenelzine sulfate (unii: 2681d7p965) (phenelzine - unii:o408n561gf) - phenelzine 15 mg - nardil has been found to be effective in depressed patients clinically characterized as "atypical," "nonendogenous," or "neurotic." these patients often have mixed anxiety and depression and phobic or hypochondriacal features. there is less conclusive evidence of its usefulness with severely depressed patients with endogenous features. nardil should rarely be the first antidepressant drug used. rather, it is more suitable for use with patients who have failed to respond to the drugs more commonly used for these conditions. nardil should not be used in patients who are hypersensitive to the drug or its ingredients, with pheochromocytoma, congestive heart failure, severe renal impairment or renal disease, a history of liver disease, or abnormal liver function tests. the potentiation of sympathomimetic substances and related compounds by mao inhibitors may result in hypertensive crises (see warnings). therefore, patients being treated with nardil should not take sympathomimetic drugs (including amphetamines, co

Australia - English - Department of Health (Therapeutic Goods Administration)

neon healthcare pty limited - phenelzine sulfate, quantity: 25.83 mg (equivalent: phenelzine, qty 15 mg) - tablet, film coated - excipient ingredients: povidone; magnesium stearate; maize starch; mannitol; titanium dioxide; hypromellose; hyprolose; sunset yellow fcf; purified talc; erythrosine; stearic acid; polyvinyl acetate phthalate - for the treatment of major depression. phenelzine sulfate should rarely be the first antidepressant drug used. rather it is more suitable for use with patients who have failed to respond to the drugs more commonly used for these conditions.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - phenelzine sulfate - oral tablet - 15mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

part viiid drug tariff special order - phenelzine sulfate - oral capsule - 15mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported - phenelzine sulfate - oral capsule - 15mg

New Zealand - English - Medsafe (Medicines Safety Authority)

link pharmaceuticals ltd - phenelzine sulfate 25.83mg equivalent to phenelzine 15 mg - film coated tablet - 15 mg - active: phenelzine sulfate 25.83mg equivalent to phenelzine 15 mg excipient: magnesium stearate maize starch mannitol opadry red 20a25096 povidone - for the treatment of major depression. phenelzine sulfate should rarely be the first antidepressant medicine used. rather it is more suitable for use with patients who have failed to respond to the medicines more commonly used for these conditions